DAE

Abstract

We discuss guiding principles for the use of response-adaptive randomization in clinical trials. First, we describe a set of criteria by which the investigator can determine whether response-adaptive randomization is useful. The we discuss a template for the appropriate selection of a response-adaptive randomization procedure. Such guidance should be useful in designing state-of-the-art clinical trials.